Speakers

Matt Drever

Vice President, Molecular Biology & Protein Engineering

Arsenal Biosciences

Andrew Phillips

Director, Bioinformatics, Biologics Engineering

AstraZeneca

Mark Kotter

Founder & Chief Executive Officer

bit.bio

Edward Green

Founder & Chief Scientific Advisor

CHAIN Biotechnology

Adam Silverman

Senior Director, Therapeutic Discovery

Codexis

Marc Güell

Co-Founder & Scientific Lead

Integra Therapeutics

Michael Daniels

Vice President, Product

Evonetix

Qi Cai

Director, Cell Biology

Kite Pharma: A Gilead Company

Héctor Garcia Martin

Staff Scientist

Lawrence Berkeley National Laboratory

Lee Cooper

Senior Director, Venture Investments

Leaps by Bayer

Michael Hudson

Director, Synthetic Biology

LifeMine Therapeutics

Ron Weiss

Professor

Massachusetts Institute of Technology

Grant Murphy

Executive Director, Discovery Biologics

Merck & Co.

Lauren Popov

Director, Translational Biology

Novome Biotechnologies

Samuel Schaffter

Bioengineer

National Institute of Standards & Technology

Tariq Warsi

Head of Technical Operations

Novome Biotechnologies

Justin Letendre

Scientist, Synthetic Biology

Strand Therapeutics

Philipp Lorenz

Chief Technology Officer

Basecamp Research

Russell Gordley

Senior Director, Gene Circuit Discovery

Senti Biosciences

Yu Qiu

Digital Biologics Advanced Application Lead

Sanofi

Dave Hava

Chief Scientific Officer

Synlogic

David James

Chief Scientific Officer

SynGenSys

Jake Becraft

Co-Founder & Chief Executive Officer

Strand Therapeutics

Maria Soloveychik

Co-Founder & Chief Executive Officer

SyntheX

Rebecca Nugent

Vice President, Platform Research

Synthego

Stuart Licht

Scientific Director, Protein Science

Moderna